Blood cancers don’t just give up, so neither do we.
In CAR-T cell therapy, scientists engineer immune cells to target specific types of blood cancer, using the body’s own immune defenses to tackle the cancer.
Haemophilia never lets up, so neither can we.
Gene therapies offer a potential life change for patients with haemophilia B, and we won’t rest until similar rare diseases can be relieved or even cured.
Lung cancer doesn’t stand still, so we don’t either.
Combining cancer treatments increases their power, helping people live healthier lives; we won’t rest until NSCLC can be kept under control or even cured.
Alzheimer’s never takes a break, so neither can we.
Alzheimer’s disease is one of Europe’s largest public health crises, but we won’t rest until new treatments can halt it in its tracks.
Diabetes doesn’t take time off, so we can’t either.
We won’t rest until cell therapy can replace a lifetime of continuous insulin therapy for patients with diabetes.
Bacterial infections never sleep, so neither do we.
We won’t rest until antibacterial monoclonal antibodies can slow antibiotic resistance and fight bacterial infections.